Free Trial

Galectin Therapeutics (GALT) Institutional Ownership

Galectin Therapeutics logo
$1.30 -0.08 (-5.47%)
As of 12:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Galectin Therapeutics (NASDAQ:GALT)

Current
Institutional Ownership
Percentage
11.68%
Number of
Institutional Buyers
(last 12 months)
29
Total
Institutional Inflows
(last 12 months)
$3.74M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$628.35K
Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

GALT Institutional Buying and Selling by Quarter

Galectin Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/25/2025 Sovran Advisors LLC199,830$244K0.0%+7.4%0.316%
4/16/2025 Wealth Enhancement Advisory Services LLC36,141$44K0.0%-29.8%0.057%
3/17/2025 Wealth Enhancement Advisory Services LLC51,510$66K0.0%+46.8%0.082%
2/17/2025Vivaldi Capital Management LP45,628$56K0.0%+89.9%0.073%
2/17/2025Bank of America Corp DE38,358$49K0.0%+101.4%0.061%
2/14/2025Northern Trust Corp244,274$315K0.0%+4.3%0.389%
2/14/2025Two Sigma Securities LLC28,571$37K0.0%N/A0.046%
2/13/2025Barclays PLC54,634$71K0.0%+91.1%0.087%
2/12/2025Geode Capital Management LLC870,589$1.12M0.0%+0.9%1.387%
2/12/2025JPMorgan Chase & Co.59,693$77K0.0%+94.9%0.095%
2/11/2025LPL Financial LLC138,928$179K0.0%+69.6%0.221%
2/10/2025Commonwealth Equity Services LLC134,518$174K0.0%-72.2%0.214%
2/7/2025HighTower Advisors LLC22,486$29K0.0%N/A0.036%
2/7/2025Inspire Advisors LLC21,095$27K0.0%+86.3%0.034%
2/7/2025PNC Financial Services Group Inc.20,000$26K0.0%N/A0.032%
2/4/2025 Bank of New York Mellon Corp50,826$66K0.0%+19.0%0.081%
1/31/2025 D.A. Davidson & CO.19,000$25K0.0%-38.3%0.030%
1/31/2025Sanctuary Advisors LLC58,413$73K0.0%-26.2%0.093%
1/29/2025 Retirement Guys Formula LLC155,343$200K0.1%+143.4%0.248%
1/29/2025 Sovran Advisors LLC186,014$240K0.0%N/A0.296%
1/27/2025Stratos Wealth Partners LTD.51,550$66K0.0%+27.4%0.082%
1/21/2025Geneos Wealth Management Inc.388,935$502K0.0%+10.2%0.620%
1/17/2025Traynor Capital Management Inc.55,670$72K0.0%+29.9%0.089%
1/10/2025 Wealth Enhancement Advisory Services LLC51,369$66K0.0%+46.4%0.082%
12/26/2024JPMorgan Chase & Co.30,628$84K0.0%+161.3%0.049%
11/25/2024Sanctuary Advisors LLC79,113$220K0.0%-21.4%0.126%
11/19/2024Barclays PLC28,587$79K0.0%+309.0%0.046%
11/18/2024Soltis Investment Advisors LLC140,750$387K0.0%N/A0.226%
11/16/2024Geode Capital Management LLC862,542$2.37M0.0%+2.5%1.385%
11/15/2024Barclays PLC28,587$79K0.0%+309.0%0.046%
11/15/2024Kovitz Investment Group Partners LLC42,540$117K0.0%N/A0.068%
11/15/2024State Street Corp251,014$690K0.0%+9.3%0.403%
11/13/2024 D.A. Davidson & CO.30,771$85K0.0%-36.9%0.049%
10/28/2024Gladstone Institutional Advisory LLC21,750$60K0.0%N/A0.035%
10/21/2024 Retirement Guys Formula LLC63,817$175K0.1%+55.1%0.103%
9/5/2024Sanctuary Advisors LLC100,658$227K0.0%N/A0.162%
8/14/2024Squarepoint Ops LLC84,074$190K0.0%+75.4%0.135%
8/14/2024Marshall Wace LLP18,825$43K0.0%N/A0.030%
8/1/2024 Rhumbline Advisers19,275$44K0.0%N/A0.031%
7/31/2024Commonwealth Equity Services LLC483,351$1.09M0.0%+317.6%0.778%
How to invest in Elon Musk’s Optimus before its launch (Ad)

Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.

7/26/2024 Bank of New York Mellon Corp64,423$146K0.0%N/A0.104%
7/24/2024Traynor Capital Management Inc.42,871$97K0.0%+23.5%0.069%
5/10/2024Vanguard Group Inc.1,979,891$4.73M0.0%+2.0%3.198%
5/7/2024Wealthspire Advisors LLC398,374$952K0.0%+116.7%0.644%
5/4/2024Geneos Wealth Management Inc.408,850$977K0.0%-0.9%0.660%
4/19/2024 Retirement Guys Formula LLC33,732$81K0.0%+56.9%0.054%
2/6/2024Solutions 4 Wealth Ltd36,085$60K0.2%N/A0.058%
2/2/2024Atria Wealth Solutions Inc.249,800$415K0.0%-3.8%0.404%
2/1/2024Cutter & CO Brokerage Inc.117,488$195K0.1%-9.3%0.190%
1/22/2024 Retirement Guys Formula LLC21,500$36K0.0%+87.0%0.035%
1/9/2024 Beacon Capital Management LLC23,905$40K0.0%+89.6%0.039%
11/8/2023 D.A. Davidson & CO.37,825$73K0.0%+15.2%0.061%
10/16/2023Traynor Capital Management Inc.34,707$67K0.0%N/A0.056%
10/11/2023AE Wealth Management LLC26,841$52K0.0%+72.7%0.043%
8/3/2023Atria Wealth Solutions Inc.260,800$376K0.0%-3.7%0.439%
7/25/2023 Summit Trail Advisors LLC20,000$29K0.0%N/A0.034%
7/13/2023 Cambridge Investment Research Advisors Inc.134,332$193K0.0%-5.7%0.226%
5/12/2023Independent Advisor Alliance36,100$76K0.0%N/A0.061%
5/9/2023Wealthspire Advisors LLC183,862$386K0.0%N/A0.309%
5/9/2023Wedbush Securities Inc.15,498$33K0.0%-36.7%0.026%
4/25/2023Geneos Wealth Management Inc.427,400$898K0.1%-1.7%0.719%
2/7/2023Commonwealth Equity Services LLC101,522$114K0.0%+165.6%0.170%
2/7/2023Benjamin F. Edwards & Company Inc.34,412$39K0.0%+78.7%0.058%
2/3/2023Cutter & CO Brokerage Inc.129,488$146K0.0%-23.6%0.217%
1/31/2023Geneos Wealth Management Inc.434,800$491K0.0%-2.3%0.729%
11/7/2022 D.A. Davidson & CO.32,810$53K0.0%-27.6%0.055%
7/28/2022 D.A. Davidson & CO.45,335$59K0.0%-18.0%0.076%
7/19/2022Commonwealth Equity Services LLC38,220$50K0.0%+42.1%0.064%
5/4/2022Advisor Group Holdings Inc.1,265,820$2.04M0.0%+1.5%2.133%
5/4/2022Commonwealth Equity Services LLC26,902$43K0.0%+59.2%0.045%
5/3/2022Cutter & CO Brokerage Inc.169,578$273K0.1%-7.6%0.286%
2/9/2022Geneos Wealth Management Inc.480,767$995K0.0%-2.2%0.810%
2/7/2022Benjamin F. Edwards & Company Inc.29,615$61K0.0%+25.5%0.050%
2/7/2022 Ameritas Advisory Services LLC44,232$92K0.0%N/A0.075%
2/3/2022 Cambridge Investment Research Advisors Inc.153,027$317K0.0%-7.0%0.258%
2/3/2022Advisor Group Holdings Inc.1,247,401$2.58M0.0%-2.1%2.102%
11/16/2021Squarepoint Ops LLC39,191$152K0.0%-30.2%0.066%
11/15/2021Capstone Investment Advisors LLC42,260$164K0.0%N/A0.071%
11/12/2021Ameritas Investment Company LLC44,232$172K0.0%+12.7%0.075%
11/12/2021Centaurus Financial Inc.22,614$88K0.0%+44.8%0.038%
11/12/2021Geode Capital Management LLC540,866$2.10M0.0%+32.2%0.912%
11/10/2021Buckingham Strategic Wealth LLC10,734$42K0.0%N/A0.018%
11/9/2021BlackRock Inc.787,582$3.06M0.0%-0.8%1.328%
11/8/2021 Keybank National Association OH100,000$388K0.0%N/A0.169%
11/4/2021QCI Asset Management Inc. NY55,000$213K0.0%+120.0%0.093%
11/2/2021Raymond James & Associates13,096$51K0.0%N/A0.022%
11/2/2021Benjamin F. Edwards & Company Inc.23,600$92K0.0%-32.0%0.040%
11/2/2021 Cambridge Investment Research Advisors Inc.164,498$638K0.0%-2.3%0.277%
10/29/2021Commonwealth Equity Services LLC11,902$46K0.0%N/A0.020%
10/8/2021Wedbush Securities Inc.30,998$120K0.0%+72.2%0.052%
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
9/3/2021Parametric Portfolio Associates LLC56,047$179K0.0%+62.9%0.096%
8/25/2021Marshall Wace LLP47,509$152K0.0%N/A0.082%
8/17/2021Millennium Management LLC568,690$1.82M0.0%N/A0.979%
8/17/2021Boothbay Fund Management LLC10,965$35K0.0%N/A0.019%
8/16/2021Squarepoint Ops LLC56,128$180K0.0%N/A0.097%
8/16/2021Ameritas Investment Company LLC39,232$126K0.0%N/A0.068%
8/16/2021LMR Partners LLP19,285$62K0.0%N/A0.033%
8/16/2021Charles Schwab Investment Management Inc.17,413$56K0.0%-77.5%0.030%
8/16/2021State Street Corp158,759$508K0.0%-74.2%0.273%
8/16/2021Tibra Equities Europe Ltd98,700$316K0.1%N/A0.170%
(Data available from 1/1/2016 forward)

GALT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of GALT shares?

During the previous two years, 39 institutional investors and hedge funds held shares of Galectin Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($4.73M), Geode Capital Management LLC ($1.12M), Wealthspire Advisors LLC ($952K), State Street Corp ($690K), Geneos Wealth Management Inc. ($502K), Atria Wealth Solutions Inc. ($415K), and Soltis Investment Advisors LLC ($387K).Learn more on GALT's institutional investors.

What percentage of Galectin Therapeutics stock is owned by institutional investors?

11.68% of Galectin Therapeutics stock is owned by institutional investors. Learn more on GALT's institutional investor holdings.

Which institutional investors have been buying Galectin Therapeutics stock?

Of the 35 institutional investors that purchased Galectin Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wealthspire Advisors LLC ($398.37K), Commonwealth Equity Services LLC ($367.61K), Sovran Advisors LLC ($199.83K), Soltis Investment Advisors LLC ($140.75K), Retirement Guys Formula LLC ($136.42K), Sanctuary Advisors LLC ($100.66K), and Bank of New York Mellon Corp ($72.53K).

How much institutional buying is happening at Galectin Therapeutics?

Institutional investors have bought a total of 2,204,205 shares in the last 24 months. This purchase volume represents approximately $4.45M in transactions.

Which Galectin Therapeutics major shareholders have been selling company stock?

Of the 9 institutional investors that sold Galectin Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commonwealth Equity Services LLC ($348.75K), Sanctuary Advisors LLC ($42.25K), D.A. Davidson & CO. ($29.77K), Atria Wealth Solutions Inc. ($19.90K), Wealth Enhancement Advisory Services LLC ($15.37K), Cutter & CO Brokerage Inc. ($12K), and Wedbush Securities Inc. ($9K).

How much institutional selling is happening at Galectin Therapeutics?

Institutional investors have sold a total of 488,902 shares in the last 24 months. This volume of shares sold represents approximately $709.65K in transactions.



This page (NASDAQ:GALT) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners